Rubicon Research Ltd

RUBICON

Company Profile

  • Business description

    Rubicon Research Ltd is a pharmaceutical company focusing on developing and manufacturing specialty and generic pharmaceutical products. Its portfolio spans multiple dosage forms, including oral solids, liquids, nasal, ophthalmic, injectable, topical, drug-device combinations, and fixed-dose combinations. The company leverages proprietary drug delivery technologies, like RubiSRL and RubiReten, and formulation expertise to address complex development challenges. It operates manufacturing and R&D facilities in India, Canada, and the United States. Rubicon generates revenue by supplying these diverse pharmaceutical products to regulated markets globally. Subsidiaries support product development, personal wellness offerings in India, and pharmaceutical training through a learning platform.

  • Contact

    Road No. 33
    MedOne House, B-75
    Wagle Estate
    Thane WestMH400 604
    IND

    T: +91 2261414000

    https://www.rubicon.co.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2026

    Employees

    1,141

Stocks News & Analysis

stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.
stocks

New production imminent for undervalued ASX gas play

LNG project receives first commissioning gas.
stocks

Going into earnings, is Tesla stock a buy, a sell, or fairly valued?

Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,324.6040.800.44%
CAC 408,201.9827.780.34%
DAX 4024,226.46395.471.66%
Dow JONES (US)46,469.36278.750.60%
FTSE 1009,405.2050.630.54%
HKSE25,858.83611.732.42%
NASDAQ22,915.18235.211.04%
Nikkei 22549,185.501,603.353.37%
NZX 50 Index13,344.9655.750.42%
S&P 5006,715.4551.440.77%
S&P/ASX 2009,031.9043.700.49%
SSE Composite Index3,863.8924.140.63%

Market Movers